|
1. Jakobsson B, Esbjomer E, Hansson S. Minimum incidence and diagnostic rate of first urinary tract infection. Pediatrics 1999;104:222-6. 2. Hellström A, Hansson E, Hansson S, Hjalmas K, Jodal U. Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child 1991;66:232-4. 3. Stokland E, Hellström M, Jacobsson B, Jodal U, Sixt R. Renal damage one year after first urinary tract infection: role of dimercaptosuccinic acid scintigraphy. J Pediatr 1996;129:815-20. 4. Rushton HG. Urinary tract infections in children: epidemiology, evaluation, and management. Pediatr Clin North Am 1997;44:1133-69. 5. Jacobson SH, Eklof O, Lins LE, Wikstad I, Winberg J. Long-term prognosis of post-infectious renal scarring in relation to radiological findings in childhood: a 27-year follow-up. Pediatr Nephrol 1992;6:19-24. 6. Jakobsson B, Berg U, Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child 1994;70:111-5. 7. Jodal U, Lindberg U, Lincoln K. Level diagnosis of symptomatic urinary tract infection in childhood. Acta Paediatr Scand 1975;64:201-7. 8. Hellerstein S, Duggan E, Welchert E, Mansour F. Serum C-reactive protein and 7 9 the site of urinary tract infections. J Pediatr 1982;100:21-5. 9. Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis DE. Prevalence of urinary tract infection in febrile infants. J Pediatr 1993;123:17-23. 10. Ilyas M, Mastin ST, Richard GA. Age-related radiological imaging in children with acute pyelonephritis. Pediatr Nephrol 2002;17:30-4. 11. Miller T, Phillips S. Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy. Kidney Int 1981;19:654-62. 12. Biggi A, Dardanelli L, Pomero G, Cussino P, Noello C, Sernia O, et al. Acute renal cortical scintigraphy in children with first urinary tract infection. Pediatr Nephrol 2001;16: 733-8. 13. Rushton HG. The evaluation of acute pyelonephritis and renal scarring with technetium 99m-dimercaptosuccinic acid renal scaintigraphy: evolving concepts and future directions. Pediatr. Nephrol 1997;11:108-20. 14. Traisman ES, Conway JJ, Traismsn HS, Yogev R, Firlit C, Shkolnik A, et al. The localization of urinary tract infection with 99m-Tc glucoheptonate scintigraphy. Pediatr Radiol 1986;16:403-6. 15. Sty JR, Wells RG, Starshak RJ, Schroeder BA. Imaging in acute renal infection in children. AJR 1987;148:471-7. 16. Rushton HG, Majd M, Chandra R, Yim D. Evaluation of 8 0 99m-technetium-dimercaptosuccinic acid renal scans and experimental acute pyelonephritis in piglets. J Urol 1988;140:1169-74. 17. Parkhouse HF, Godley ML, Cooper J, Risdon RA, Ransley PG. Renal imaging with 99m-Tc-labelled DMSA in the detection of acute pyelonephritis: an experimental study in the pig. Nucl Med Commun 1989;10:63-70. 18. Lange MJ, Piers DA, Kosternik JGW, Lujik WHJ, Meijer S, Zeeuw D, Hem GK. Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake. J Nucl Med 1989;30:1219-25. 19. Majd M, Rushton HG. Renal cortical scintigraphy in the diagnosis of acute pyelonephritis. Semin Nucl Med 1992;22:98-111. 20. Hill GS, Clark RL. A comparative angiographic, microangiographic, and histologic study of experimental pyelonephritis. Invest Radiol 1972;7:33-47. 21. Goldraich NP, Goldraich JH. Update on dimercaptosuccinic acid renal scanning in children with urinary tract infection. Pediatr Nephrol 1995;9:221-6. 22. Curfs JH, Meis JF, Hoogkamp-Korstanje JA. A primer on cytokines: source, receptors, effects, and inducers. Clin Microbiol Rev 1997;10:742-80. 23. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993; 328:106-13. 24. Hedges S, Agace W, Svensson M, Sjogren A-C, Ceska M, Svanborg C. 8 1 Uroepithelial cells are part of a mucosal cytokine network. Infect Immun 1994;62:2315-21. 25. Tullus K, Wang JA, Lu Y, Burman LG, Brauner A. Interleukin-1α and interleukin-6 in the urine, kidney, and bladder of mice inoculated with Escherichia coli. Pediatr Nephrol 1996;10:453-7. 26. Kaboré AF, Simard M, Bergeron MG: Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis. J Infect Dis 1999;179:1162-72. 27. Gürgöze MK, Akarsu S, Yimaz E, Gödekmerdan A, Akca Z, Ciftci I, et al. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol 2005;20:1445-8. 28. Krzemień G, Roszkowska-Blaim M, Kostro I, Szmigielska A, Karpinska M, Sieniawska M, et al. Urinary levels of interleukin-6 and interleukin-8 in children with urinary tract infection to the age of 2. Med Sci Monit 2004;10:CR593-7. 29. Jantausch BA, O’Donnell R, Wiedermann BL. Urinary interleukin-6 and interleukin-8 in children with urinary tract infection. Pediatr Nephrol 2000;15:236-40. 30. Kassir K, Vargas-Shiraishi O, Zaldivar F, Berman M, Singh J, Arrieta A. Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: 8 2 potential therapeutic impact. Clin Diagn Lab Immunol 2001;8:1060-3. 31. Otto G, Braconier J, Andreasson A, Svanborg C. Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection. J Infect Dis 1999;179:172-9. 32. Benson M, Jodal U, Agace W, Hellström M, Mårild S, Rosberg S, et al. Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria. J Infect Dis 1996;174:1080-4. 33. Tullus K, Escobar-Billing R, Fituri O, Burman LG, Karlsson A, Wikstad I, et al. Interleukin-1α and interleukin-1 receptor antagonist in the urine of children with acute pyelonephritis and relation to renal scarring. Acta Paediatr 1996; 85:158-62. 34. Dinarello CA. Interleukin-1β. Crit Care Med 2005; 33:S460-2. 35. Starnes HF. Biological effects and possible clinical applications of interleukin 1. Sem Hematol 1991;28:34-9. 36. Martins SM, Darlin DJ, Lad PM, Zimmern PE. Interleukin-1β: A clinically relevant urinary marker. J Urol 1994;151:1198-201. 37. Davidoff R, Yamaguchi R, Leach GE, Park E, Lad Pramod M. Multiple urinary cytokine levels of bacterial cystitis. J Urol 1997;157:1980-5. 38. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a paradism for cytokines. Science 1992;258:593-7. 8 3 39. Uehling DT, Johnson DB, Hopkins WJ. The urinary tract response to entry of pathogen. World J Urol 1999;17:351-8. 40. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990;265:621-36. 41. Hack CE, Degroot ER, Felt-Bersma RJF, Nuijens JH, Van Schijndel RJ, Eerenberg-Belmer AJM, et al. Increased plasma levels of interleukin-6 in sepsis. Bolld 1989;74:1704-10. 42. Tullus K, Fituri O, Linné T, Escobar-Billing R, Wikstad I, Karlsson A, et al. Urine interleukin-6 and interleukin-8 in children with acute pyelonephritis, in relation to DMSA scintigraphy in the acute phase and at 1-year follow-up. Pediatr Radiol 1994;24:513-15. 43. Benson M, Jodal U, Andreasson A, Karlsson Å, Rydberg J, Svanborg C. Interleukin-6 response to urinary tract infection in childhood. Pediatr Infect Dis J 1994;13:612-6. 44. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9. 45. Godaly G, Proudfoot AEI, Offord R, Svanborg C, Agace WW. Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration. Infect Immun 1997;65:3451-6. 8 4 46. Ko Y-C, Mukaida N, Ishiyama S, Tokue A, Kawai T, Matsushima K, et al. Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun 1993;61:1307-14. 47. Jahnukainen T, Chen M, Celsi G. Mechanisms of renal damage owing to infection. Pediatr Nephrol 2005;20:1043-53. 48. Haraoka M, Senoh K, Ogata N, Furukawa M, Matsumoto T, Kumazawa. Elevated interleukin-8 levels in the urine of children with renal scarring and/or vesicoureteral reflux. J Urol 1996;155:678-80. 49. Galanakis E, Bitsori M, Dimitriou H, Giannakopoulou C, Karkavitsas NS, Kalmanti M. Urine interleukin-8 as a marker of vesicoureteral reflux in infants. Pediatrics 2006;117:e863-7. 50. Hang L, Frendeus B, Godaly G, Svanborg C. Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis 2000;182:1738-48. 51. Patel K, Charron M, Hoberman A, Brown ML, Rogers KD. Intra and interobserver variability in interpretation of DMSA scans using a set of standardized criteria. Pediatr Radiol 1993;23:506-9. 52. International Reflux Study in Children. International system of radiographic grading of vesicoureteric reflux. Pediatr Radiol 1985;15:105-9. 8 5 53. Rugo HS, O’Hanley P, Bishop AG, Pearse MK, Abrams JS, Howard M, et al: Local cytokine production in a murine model of Escherichia coli pyelonephritis. J Clin Invest 1992;89:1032-9. 54. Fünfstück R, Franke S, Hellberg M, Ott U, Knöfel B, Straube E, et al. Secretion of cytokines by uroepithelial cells stimulated by Escherichia coli and Citrobacter spp. Infect J Antimicrol Agent 2001;17:253-8. 55. Roilides E, Papachristou F, Gioulekas E, Tsaparidou S, Karatzas N, Sotiriou J, et al. Increased urine interleukin-6 concentration correlated with pyelonephritis changes on 99mTc-dimercaptosuccinic acid scan in neonates with urinary tract infection. J Infect Dis 1999;180:904-7. 56. Arrieta AC, Sequeira LA, Vargas-Shiraishi OM, Lang DA, Sandborg CI. Interleukin (IL)-1α and -β and IL-6 in urine and serum of children with urinary tract infection: diagnostic implications. Pediatr Res 1995;37:169A. 57. Schibler KR, Liechty KW, White WL, Rothstein G, Christensen RD. Defective production of interleukin-6 by monocytes: a possible mechanism underlying several host defense deficiencies of neonates. Pediatr Res 1992;31:18-21. 58. Downs SM. Technique report: urinary tract infection in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 1999;103:e54-8. 8 6 59. Fanos V, Cataldi L. Antibiotics or surgery for vesicoureteral reflux in children. Lancet 2004;353:1720-2. 60. Ninan GK, Singh Jutley R, Eremin O. Urinary cytokines as markers of reflux nephropathy. J Urol 1999;162:1739-42. 61. Jacobson SH, Hylander B, Wretlind B, Brauner A. Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function. Nephron 1994;67:172-9. 62. Khalil A, Brauner A, Bakhiet M, Burman LG, Jaremko G, Wretlind B, et al. Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice. J Uro 1997;158:1576-80. 63. Dinarello CA. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 2000;343:732-4. 64. Zhang Y, McCluskey K, Fujii K, Wahl LM. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J Immunol 1998;161:3071-6. 65. Khalil A, Tullus K, Bartfai T, Bakhiet M, Jaremko G, Brauner A. Renal cytokine responses in acute Escherichia coli pyelonephritis in IL-6-deficient mice. Clin Exp Immunol 2000;122:200-6. 8 7 66. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994;331:1286-92, 67. Hertting O, Khalil A, Jaremko G, Chromek M, Li YH, Bakhiet M, et al. Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1β-deficienct mice. Clin Exp Immunol 2003;131:225-33. 68. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-β1 underlines development of progressive kidney fibrosis. Kidney Int 1994;45:916-27. 69. Peters H, Norble NA, Border WA. Transforming growth factor-beta in human glomerular injury. Curr Opin Nephrol Hypertens 1997;6:389-93. 70. Border WA, and Noble NA. TGF-β in kidney fibrosis: A target for gene therapy. Kidney Int 1997;1388-96. 71. Cotton SA, Gbadegesin RA, Williams S, Brenchley PEC, Webb NJA. Role of TGF-β1 in renal parenchymal scarring following childhood urinary tract infection. Kidney Int 2002;61:61-7. 72. Farmaki E, Papachristou F, Winn RM, Karatzas N, Sotiriou J, Roilides E. Transforming growth factor-β1 in the urine of young children with urinary tract infection. Pediatr Nephrol 2005;20:180-3. 73. Shahin R, Engberg I, Hagberg L, Svanborg-Eden C. Neutrophil recruitment and 8 8 bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol 1987;138:3475-80. 74. Agace W, Hedges S, Ceska M, Svanborg C. IL-8 and the neutrophil response to mucosal gram-negative infection. J Clin Invest 1993;92:780-5. 75. Haraoka M, Hang L, Frendéus B. Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis 1999;180:1220-9. 76. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg C. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 1984;46:839-44. 77. Frendéus B, Godaly G, Hang L, Karpman D, Lundstedt AC, Svanborg C. Interleukin-8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 2000;192:881-90. 78. Hang L, Frendéus B, Godaly G, Svanborg C. Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis 2000;182:1738-48. 79. Frendéus B, Godaly G, Hang L, Karpman D, Svanborg C. Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis. J Infect Dis 2001;183 (Suppl):S56-60. 80. Rao WH, Evans GS, Finn A. The significance of interleukin 8 in urine. Arch Dis Child 2001;85:256-62.
|